新型抗脂抗体与不良妊娠结果之间的关联
Kimberly A Moyle1, D Ware Branch, Lisa K Peterson
1University of Utah and ARUP Laboratories, Salt Lake City, and Intermountain Health, Murray, Utah; the Hospital for Special Surgery, New York, New York; and Oregon Health & Science University, Portland, Oregon.
Obstetrics and gynecology
|December 12, 2024
概括
抗β2糖蛋白-I域1 (aD1) 和抗固醇蛋白-原素IgG抗体是危险人群不良妊娠结果的强有力的预测因素. 它们的联合使用可能有助于识别患有严重产科并发症风险最高的患者.
科学领域:
- 生殖免疫学和产科生殖免疫学
- 血栓形成和血液静止的研究.
背景情况:
- 抗脂抗体 (aPL) 与不良妊娠结果有关.
- 特定的aPL的预测价值,如抗β2糖蛋白-I域1 (aD1) 和抗固醇原抗体,需要在风险人群中进一步调查.
研究的目的:
- 评估aD1和antiphosphatidylserine-prothrombin抗体对不良妊娠结果的预测价值.
- 探索aD1,antiphosphatidylserine-prothrombin,狼抗凝剂和其他aPL之间的关系.
主要方法:
- 有或没有系统性红斑狼 (SLE) 和/或aPL的孕妇患者的前性队列研究 (PROMISSE).
- 在妊娠早期血清中量化aD1和抗酸胺-前列血水平.
- 接收器操作特征 (ROC) 分析和多变量回归建模以评估不良妊娠结果的预测.
主要成果:
- aD1和抗固醇蛋白-原素IgG显示出对不良妊娠结果的显著预测价值 (AUC分别为0.734和0.830).
- 在多变量建模中,狼抗凝剂,aD1和抗酸胺-原蛋白IgG被确定为独立预测剂.
- 在阳性狼抗凝剂,aD1和抗胺-前列腺素IgG (47.6%) 的患者中观察到高比例的不良妊娠结果.
结论:
- aD1和抗固醇蛋白-原素IgG是aPL孕妇不良妊娠结果的显著独立预测因素.
- 这些抗体与狼抗凝剂的阳性强烈相关.
- 这些标记物的联合评估可以识别患有严重产科并发症的高风险患者.
相关概念视频
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Rh Blood Group
1.3K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Mitral Valve Prolapse III: Nursing Management
4
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
4
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K


